tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

MPS North America to Acquire Unbound Medicine in Strategic Healthcare Tech Push

Story Highlights
  • MPS North America LLC will acquire Unbound Medicine, a leading North American digital medical information provider.
  • The acquisition marks MPS Limited’s strategic entry into healthcare IT, boosting recurring revenues, innovation and North American presence.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
MPS North America to Acquire Unbound Medicine in Strategic Healthcare Tech Push

Claim 50% Off TipRanks Premium

The latest update is out from MPS Limited ( (IN:MPSLTD) ).

MPS North America LLC, the wholly owned U.S. subsidiary of MPS Limited, has agreed to acquire a 100% stake in Unbound Medicine, Inc., a U.S.-based provider of digital medical reference, clinical decision-support, and healthcare learning solutions that serves medical schools, hospital systems, and professional associations across the United States and Canada via mobile-first and web-based platforms. The deal marks MPS Limited’s entry into the healthcare and medical information technology segment and is positioned as a transformative strategic milestone, expected to diversify revenue, deepen the company’s presence in the North American market, unlock cross-selling and AI-driven innovation opportunities, and strengthen its role as a technology-first partner to the global healthcare community.

More about MPS Limited

MPS Limited is a digital publishing and technology-enabled content solutions company with significant operations in North America and India. Through its subsidiary MPS North America LLC, the group focuses on platform-led, recurring-revenue businesses built around digital content, learning platforms, and technology services for knowledge-intensive industries.

Average Trading Volume: 1,190

Technical Sentiment Signal: Buy

Current Market Cap: 32.01B INR

Find detailed analytics on MPSLTD stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1